World's Best Scientists 2026 revealed!
Francis K. Buadi

Francis K. Buadi

D-Index & Metrics

Medicine

D-Index
91
Citations
32729
World Ranking
11697
National Ranking
6001

Overview

Francis K. Buadi is affiliated with the Mayo Clinic in the United States and has contributed extensively to research in medicine, with a particular focus on hematology and molecular biology. Their scholarly work intersects multiple disciplines, including oncology, genetics, and nephrology, reflecting a multidisciplinary approach to complex medical conditions.

The primary fields of study in Francis K. Buadi's research include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Within these domains, the subfields of Hematology, Molecular Biology, Oncology, Genetics, and Nephrology are prominent in their publications. Their research centers on several key topics:

  • Multiple Myeloma Research and Treatments
  • Amyloidosis: Diagnosis, Treatment, Outcomes
  • Protein Degradation and Inhibitors
  • Chronic Lymphocytic Leukemia Research
  • Peptidase Inhibition and Analysis
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Cancer Treatment and Pharmacology

Francis K. Buadi's publication record is demonstrated through contributions to numerous peer-reviewed journals. The most frequent publication venues for their work are:

  • Blood
  • Clinical Lymphoma Myeloma & Leukemia
  • Blood Cancer Journal
  • Journal of Clinical Oncology
  • American Journal of Hematology

Recent papers represent diverse topics, including systemic amyloidosis and genetic abnormalities in multiple myeloma, with the following notable examples:

  • Systemic amyloidosis from A (AA) to T (ATTR): a review, 2020, Journal of Internal Medicine
  • Cytogenetic abnormalities in multiple myeloma: association with disease characteristics and treatment response, 2020, Blood Cancer Journal
  • Final Overall Survival Analysis of the TOURMALINE-MM1 Phase III Trial of Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma, 2021, Journal of Clinical Oncology
  • Clinical characteristics and treatment outcomes of newly diagnosed multiple myeloma with chromosome 1q abnormalities, 2020, Blood Advances
  • Mortality trends in multiple myeloma after the introduction of novel therapies in the United States, 2021, Leukemia

The collaboration network of Francis K. Buadi features several frequent co-authors including Angela Dispenzieri, Morie A. Gertz, Prashant Kapoor, Shaji Kumar, and David Dingli, indicating active engagement in joint research efforts within the hematology and oncology communities.

Best Publications

  • Improved survival in multiple myeloma and the impact of novel therapies

    Shaji K. Kumar;S. Vincent Rajkumar;Angela Dispenzieri;Martha Q. Lacy

  • Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients

    S K Kumar;A Dispenzieri;M Q Lacy;M A Gertz

  • Revised Prognostic Staging System for Light Chain Amyloidosis Incorporating Cardiac Biomarkers and Serum Free Light Chain Measurements

    Shaji Kumar;Angela Dispenzieri;Martha Q. Lacy;Suzanne R. Hayman

  • Oral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma

    Philippe Moreau;Tamás Masszi;Norbert Grzasko;Nizar J Bahlis

  • A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma

    David S. Siegel;Thomas Martin;Michael Wang;Ravi Vij

  • Management of Newly Diagnosed Symptomatic Multiple Myeloma: updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines

    Shaji K. Kumar;Joseph R. Mikhael;Francis K. Buadi;David Dingli

  • Pomalidomide (CC4047) Plus Low-Dose Dexamethasone As Therapy for Relapsed Multiple Myeloma

    Martha Q. Lacy;Suzanne R. Hayman;Morie A. Gertz;Angela Dispenzieri

  • Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myeloma.

    S Kumar;A Dispenzieri;M Q Lacy;S R Hayman

  • Induction of a Chronic Disease State in Patients With Smoldering or Indolent Multiple Myeloma by Targeting Interleukin 1β-Induced Interleukin 6 Production and the Myeloma Proliferative Component

    John A. Lust;Martha Q. Lacy;Steven R. Zeldenrust;Angela Dispenzieri

  • Improved outcomes for newly diagnosed AL amyloidosis between 2000 and 2014: cracking the glass ceiling of early death.

    Eli Muchtar;Morie A. Gertz;Shaji K. Kumar;Martha Q. Lacy

  • Remission of Disseminated Cancer After Systemic Oncolytic Virotherapy

    Stephen J. Russell;Mark J. Federspiel;Kah Whye Peng;Caili Tong

  • Pomalidomide plus low-dose dexamethasone in myeloma refractory to both bortezomib and lenalidomide: comparison of 2 dosing strategies in dual-refractory disease.

    Martha Q. Lacy;Jacob B. Allred;Morie A. Gertz;Suzanne R. Hayman

  • Trisomies in multiple myeloma: impact on survival in patients with high-risk cytogenetics.

    Shaji Kumar;Rafael Fonseca;Rhett P. Ketterling;Angela Dispenzieri

  • Pomalidomide (CC4047) plus low dose dexamethasone (Pom/dex) is active and well tolerated in lenalidomide refractory multiple myeloma (MM)

    M Q Lacy;S R Hayman;M A Gertz;K D Short

  • The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome.

    Anita D'Souza;Suzanne R. Hayman;Francis Buadi;Michelle Mauermann

  • Risk stratification of smoldering multiple myeloma incorporating revised IMWG diagnostic criteria.

    Arjun Lakshman;S. Vincent Rajkumar;Francis K. Buadi;Moritz Binder

  • Coexistent Multiple Myeloma or Increased Bone Marrow Plasma Cells Define Equally High-Risk Populations in Patients With Immunoglobulin Light Chain Amyloidosis

    Taxiarchis V. Kourelis;Shaji K. Kumar;Morie A. Gertz;Martha Q. Lacy

  • Incidence of extramedullary disease in patients with multiple myeloma in the era of novel therapy, and the activity of pomalidomide on extramedullary myeloma

    K Detweiler Short;S V Rajkumar;D Larson;F Buadi

  • Randomized Trial of Lenalidomide Versus Observation in Smoldering Multiple Myeloma.

    Sagar Lonial;Susanna Jacobus;Rafael Fonseca;Matthias Weiss

  • Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial

    Meletios A Dimopoulos;Fredrik Schjesvold;Fredrik Schjesvold;Meral Beksac

Frequent Co-Authors

Morie A. Gertz
Morie A. Gertz Mayo Clinic
Shaji Kumar
Shaji Kumar Mayo Clinic
Martha Q. Lacy
Martha Q. Lacy Mayo Clinic
David Dingli
David Dingli Mayo Clinic
Nelson Leung
Nelson Leung Mayo Clinic
Robert A. Kyle
Robert A. Kyle Mayo Clinic
John A. Lust
John A. Lust Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees is a practical option for students considering a flexible and affordable path into the medical field. Many healthcare roles, such as registered nurse or nurse practitioner, now offer reputable online programs that fit a variety of budgets and schedules.

If you’re looking to become a nurse practitioner, there are affordable online FNP programs designed to advance your qualifications without relocating or leaving your job. Similarly, those beginning their nursing journey can find some of the cheapest online nursing programs that maintain rigorous educational standards.

For those seeking leadership roles or research opportunities, pursuing an online PhD nursing program can open doors to academic and advanced clinical positions. Registered nurses aiming to broaden their skills may benefit from completing an RN to BSN online degree, which often leads to enhanced professional opportunities.

Online healthcare degrees offer greater accessibility, but it’s vital to ensure programs are properly accredited and meet your career goals before enrolling.

Best Scientists Citing Francis K. Buadi

Trending Scientists

Recently Published Articles